PET-CT After Treatment: — When and Why It Is Ordered

A rising marker after treatment is called biochemical recurrence, and it is often the first detectable sign that disease is present. PET-CT can sometimes find where disease is before symptoms appear, but not always — the deposit may be too small, or the cancer type may not take up the tracer reliably. A clear scan does not cancel out the marker. Your oncologist uses both pieces of information together, and monitoring continues either way.

Not necessarily. A bright area on PET — referred to as a hot spot or increased uptake — means the scanner found higher metabolic activity than the surrounding tissue. That can be cancer, but it can also be infection, inflammation from recent treatment, or normal activity in certain organs. Your oncologist considers location, shape, and SUV value alongside your clinical history. A biopsy or follow-up scan is often recommended before a treatment decision is made.

A plain CT shows anatomy — size and shape of structures. PET-CT adds metabolic activity across the whole body in one session, which is useful when disease may have spread to more than one location. MRI gives finer soft-tissue detail in specific areas — brain, spine, liver — without radiation. Your oncologist chooses based on what question needs answering. Sometimes more than one type of scan is needed to get the full picture.

In some situations a plain CT or MRI can answer the clinical question at lower cost. Your oncologist orders PET-CT when the metabolic information it provides is likely to change what happens next — for example, to check whether disease is localised before choosing between surgery and systemic treatment. If cost is a concern, ask whether another scan would answer the same question in your situation. Any cost figure for PET-CT is indicative and varies by centre and by date.

The scan tells your oncologist where recurrence is and how extensive it appears. That guides the next step — surgery, systemic treatment, radiotherapy, or a combination. A biopsy may still be needed to confirm the finding and to check whether the tumour's characteristics have changed since the original diagnosis. Recurrence does not mean treatment options have run out. Your oncologist will explain what is available for your specific situation.

A clear scan describes the situation at that point in time. Cancer can return in the interval, which is why follow-up is scheduled based on your risk of recurrence, your cancer type, and how things look now. A new symptom or rising marker since the last scan changes the picture entirely. The question your team asks each time is whether a new scan will give information that changes what they do next — if yes, the scan is appropriate regardless of the previous result.